• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

终末期肝病模型(MELD)评分:在非对乙酰氨基酚所致急性肝衰竭中的效用及与国王学院标准的比较

MELD score: utility and comparison with King's College criteria in non-acetaminophen acute liver failure.

作者信息

Parkash Om, Mumtaz Khalid, Hamid Saeed, Ali Shah Syed Hasnain, Wasim Jafri S M

机构信息

Department of Medicine, The Aga Khan University Hospital, Stadium Road, Karachi.

出版信息

J Coll Physicians Surg Pak. 2012 Aug;22(8):492-6.

PMID:22868013
Abstract

OBJECTIVE

To compare Model for End-stage Liver Disease Score (MELD Score, MS) and King's College Hospital (KCH) criteria for finding correlation of mortality in non-acetaminophen induced acute liver failure (NAI-ALF).

STUDY DESIGN

An analytical cross-sectional study.

PLACE AND DURATION OF STUDY

The Aga Khan University Hospital, Karachi, from 2005 to 2007.

METHODOLOGY

The study included patients with NAI-ALF. KCH criteria were labelled as good and bad prognosis groups. MELD score were calculated by using the MELD calculator. ROC was plotted and sensitivity analysis was done. ETA was used to see correlation between MELD and KCH.

RESULTS

Ninety-one patients with mean age of 32.5 + 16.3 years were studied; 49 were males (54%). Out of these, 57 patients died (63%); two leading causes of non-acetaminophen induced acute liver failure (NAI-ALF) were hepatitis hepatitis B virus (HBV) (n = 30, 33%) followed by hepatitis E virus in (n = 23, 25.3%). According to King's College Hospital (KCH) criteria, 50 patients (88%) who died had bad prognosis and 24 patients (70.6%) who survived had good prognosis. The ROC determined MELD score of 32 was the best predictor of mortality with sensitivity and specificity of 79% and 71%, respectively and positive predictive value (PPV) and negative predictive values (NPV) of 82% and 67% respectively. There was significant association between mortality and bad prognosis according to KCH criteria (p < 0.001). Overall mean MELD score (MMS) was 35.35 + 8.64. MMS on admission was 38 + 7.32 in patients who died and 30.7 + 8.77 in those who survived (p = < 0.001). MMS correlated equally with KCH criteria (ETA = 0.52).

CONCLUSION

The admission MELD score has an excellent utility and correlates equally with KCH criteria for mortality in NAI- ALF.

摘要

目的

比较终末期肝病模型评分(MELD评分,MS)和国王学院医院(KCH)标准,以确定非对乙酰氨基酚所致急性肝衰竭(NAI-ALF)患者死亡率的相关性。

研究设计

一项分析性横断面研究。

研究地点及时间

2005年至2007年在卡拉奇的阿迦汗大学医院进行。

方法

该研究纳入了NAI-ALF患者。KCH标准被分为预后良好组和预后不良组。使用MELD计算器计算MELD评分。绘制ROC曲线并进行敏感性分析。使用ETA来观察MELD与KCH之间的相关性。

结果

共研究了91例患者,平均年龄为32.5±16.3岁;其中49例为男性(54%)。在这些患者中,57例死亡(63%);非对乙酰氨基酚所致急性肝衰竭(NAI-ALF)的两个主要病因是乙型肝炎病毒(HBV)肝炎(n = 30,33%),其次是戊型肝炎病毒(n = 23,25.3%)。根据国王学院医院(KCH)标准,50例死亡患者(88%)预后不良,24例存活患者(70.6%)预后良好。ROC曲线确定MELD评分为32是死亡率的最佳预测指标,敏感性和特异性分别为79%和71%,阳性预测值(PPV)和阴性预测值(NPV)分别为82%和67%。根据KCH标准,死亡率与预后不良之间存在显著关联(p < 0.001)。总体平均MELD评分(MMS)为35.35±8.64。死亡患者入院时的MMS为38±7.32,存活患者为30.7±8.77(p = < 0.001)。MMS与KCH标准的相关性相同(ETA = 0.52)。

结论

入院时的MELD评分具有很好的实用性,并且与NAI-ALF患者死亡率的KCH标准具有相同的相关性。

相似文献

1
MELD score: utility and comparison with King's College criteria in non-acetaminophen acute liver failure.终末期肝病模型(MELD)评分:在非对乙酰氨基酚所致急性肝衰竭中的效用及与国王学院标准的比较
J Coll Physicians Surg Pak. 2012 Aug;22(8):492-6.
2
Early indicators of prognosis in fulminant hepatic failure: an assessment of the Model for End-Stage Liver Disease (MELD) and King's College Hospital criteria.暴发性肝衰竭预后的早期指标:终末期肝病模型(MELD)与国王学院医院标准的评估
Liver Transpl. 2007 Jun;13(6):814-21. doi: 10.1002/lt.21050.
3
APACHE III score is superior to King's College Hospital criteria, MELD score and APACHE II score to predict outcomes after liver transplantation for acute liver failure.急性肝衰竭肝移植术后,APACHE III评分在预测预后方面优于国王学院医院标准、终末期肝病模型(MELD)评分及APACHE II评分。
Transplant Proc. 2013 Jul-Aug;45(6):2295-301. doi: 10.1016/j.transproceed.2013.02.125.
4
MELD score as a prognostic model for listing acute liver failure patients for liver transplantation.终末期肝病模型(MELD)评分作为急性肝衰竭患者肝移植列入标准的预后模型。
Transplant Proc. 2006 Sep;38(7):2097-8. doi: 10.1016/j.transproceed.2006.06.004.
5
MELD score to predict outcome in adult patients with non-acetaminophen-induced acute liver failure.终末期肝病模型(MELD)评分用于预测非对乙酰氨基酚所致急性肝衰竭成年患者的预后。
Liver Int. 2007 Apr;27(3):329-34. doi: 10.1111/j.1478-3231.2006.01429.x.
6
Comparison of the sequential organ failure assessment score with the King's College Hospital criteria and the model for end-stage liver disease score for the prognosis of acetaminophen-induced acute liver failure.比较序贯器官衰竭评估评分与英国国王学院医院标准和终末期肝病模型评分对乙酰氨基酚诱导的急性肝衰竭预后的预测价值。
Liver Transpl. 2012 Apr;18(4):405-12. doi: 10.1002/lt.23370.
7
Comparison of Dynamic Changes Among Various Prognostic Scores in Viral Hepatitis-Related Acute Liver Failure.比较病毒性肝炎相关急性肝衰竭中各种预后评分的动态变化。
Ann Hepatol. 2018 May-June;17(3):403-412. doi: 10.5604/01.3001.0011.7384. Epub 2018 Apr 9.
8
MELD score as a predictor of liver failure and death in patients with acetaminophen-induced liver injury.终末期肝病模型(MELD)评分作为对乙酰氨基酚所致肝损伤患者肝衰竭和死亡的预测指标。
Hepatology. 2007 Mar;45(3):789-96. doi: 10.1002/hep.21503.
9
Indocyanine green clearance test combined with MELD score in predicting the short-term prognosis of patients with acute liver failure.吲哚菁绿清除试验联合终末期肝病模型(MELD)评分预测急性肝衰竭患者的短期预后
Hepatobiliary Pancreat Dis Int. 2014 Jun;13(3):271-5. doi: 10.1016/s1499-3872(14)60040-0.
10
Acute liver failure in Sweden: etiology and outcome.瑞典的急性肝衰竭:病因及预后
J Intern Med. 2007 Sep;262(3):393-401. doi: 10.1111/j.1365-2796.2007.01818.x.

引用本文的文献

1
Outcomes of patients with acute liver failure not listed for liver transplantation: A cohort analysis.未列入肝移植名单的急性肝衰竭患者的结局:一项队列分析。
Hepatol Commun. 2024 Oct 30;8(11). doi: 10.1097/HC9.0000000000000575. eCollection 2024 Nov 1.
2
Acute Liver Failure Prognostic Criteria: It's Time to Revisit.急性肝衰竭的预后标准:是时候重新审视了。
Cureus. 2023 Jan 16;15(1):e33810. doi: 10.7759/cureus.33810. eCollection 2023 Jan.
3
Creatinine-lactate score predicts mortality in non-acetaminophen-induced acute liver failure in patients listed for liver transplantation.
肌酸酐-乳酸评分预测乙酰氨基酚以外原因导致的急性肝衰竭患者在肝移植名单上的死亡率。
BMC Gastroenterol. 2021 Jun 7;21(1):252. doi: 10.1186/s12876-021-01830-5.
4
Ascites management by cell-free concentrated ascites reinfusion therapy during recovery from drug-induced acute liver injury: a case report.细胞游离浓缩腹水再输注疗法在药物性急性肝损伤恢复期间对腹水的管理:一例报告。
J Med Case Rep. 2020 Oct 14;14(1):192. doi: 10.1186/s13256-020-02507-5.
5
SOFA in the first 24 hours as an outcome predictor of acute liver failure.最初24小时的序贯器官衰竭评估(SOFA)作为急性肝衰竭的预后预测指标
Rev Bras Ter Intensiva. 2018 Mar;30(1):64-70. doi: 10.5935/0103-507x.20180012.
6
Live donor liver transplantation for antitubercular drug-induced acute liver failure.活体供肝肝移植治疗抗结核药物所致急性肝衰竭
Indian J Gastroenterol. 2017 Jan;36(1):56-61. doi: 10.1007/s12664-016-0725-1. Epub 2017 Jan 9.
7
Development of a Model to Predict Transplant-free Survival of Patients With Acute Liver Failure.预测急性肝衰竭患者无移植生存的模型的开发。
Clin Gastroenterol Hepatol. 2016 Aug;14(8):1199-1206.e2. doi: 10.1016/j.cgh.2016.03.046. Epub 2016 Apr 13.
8
A novel prognostic score for acute-on-chronic hepatitis B liver failure.一种用于慢性乙型肝炎急性肝衰竭的新型预后评分系统。
J Huazhong Univ Sci Technolog Med Sci. 2015 Feb;35(1):87-92. doi: 10.1007/s11596-015-1394-5. Epub 2015 Feb 12.
9
Steroid use in acute liver failure.急性肝衰竭中的类固醇使用。
Hepatology. 2014 Feb;59(2):612-21. doi: 10.1002/hep.26678. Epub 2013 Dec 24.